Terms: = Liver cancer AND CARS, P49589, 833, ENSG00000110619 AND Prognosis
25 results:
1. Elevated splenic 18F-fluorodeoxyglucose positron emission tomography/computed tomography activity is associated with 5-year risk of recurrence in non-metastatic invasive ductal carcinoma of the breast.
Wang Y; Li Y; Jiang H; Zuo C; Xu W
Br J Radiol; 2024 Jan; 97(1153):237-248. PubMed ID: 38263821
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of macrotrabecular-massive hepatocellular carcinoma by using MR-based models and their prognostic implications.
Chai F; Ma Y; Feng C; Jia X; Cui J; Cheng J; Hong N; Wang Y
Abdom Radiol (NY); 2024 Feb; 49(2):447-457. PubMed ID: 38042762
[TBL] [Abstract] [Full Text] [Related]
3. Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted CAR T-cell therapy: a case report.
Wang Y; Zhao Y; Li M; Hou H; Jian Z; Li W; Li P; Ma F; Liu M; Liu H; Xue H
Front Immunol; 2023; 14():1180001. PubMed ID: 37256142
[TBL] [Abstract] [Full Text] [Related]
4. Meta-analysis of the prognostic value of soluble programmed death ligand-1 (sPD-L1) in cancers.
Sun J; Hu S; Li X
Biomarkers; 2023 Sep; 28(6):477-485. PubMed ID: 37017446
[TBL] [Abstract] [Full Text] [Related]
5. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
[TBL] [Abstract] [Full Text] [Related]
6. CT-based skeletal muscle loss for predicting poor survival in patients with hepatocellular carcinoma experiencing curative hepatectomy plus adjuvant transarterial chemoembolization: a preliminary retrospective study.
Yang S; Zhang Z; Su T; Yu J; Cao S; Wang H; Jin L
Eur J Med Res; 2022 Jul; 27(1):131. PubMed ID: 35879734
[TBL] [Abstract] [Full Text] [Related]
7. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
Antonucci L; Canciani G; Mastronuzzi A; Carai A; Del Baldo G; Del Bufalo F
Front Immunol; 2022; 13():867154. PubMed ID: 35603195
[TBL] [Abstract] [Full Text] [Related]
8. Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study.
Huang C; Fang M; Xiao X; Wang H; Gao Z; Ji J; Liu L; Gu E; Li Y; Wang M; Gao C
Liver Int; 2022 Jan; 42(1):210-223. PubMed ID: 34679250
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical outcomes for young patients with muscular invasive bladder cancer who received robot-assisted radical cystectomy].
Wang JG; Zhu ZW; Fan YF; Zhang XP
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(12):861-865. PubMed ID: 33789368
[No Abstract] [Full Text] [Related]
10. prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
Zhang L; Sun JH; Hou ZH; Zhong BY; Yang MJ; Zhou GH; Wang WS; Huang P; Zhang S; Li Z; Zhu XL; Yan ZP; Ni CF
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):63-72. PubMed ID: 32965582
[TBL] [Abstract] [Full Text] [Related]
11. Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma.
Ling YH; Chen JW; Wen SH; Huang CY; Li P; Lu LH; Mei J; Li SH; Wei W; Cai MY; Guo RP
BMC Cancer; 2020 Jun; 20(1):607. PubMed ID: 32600297
[TBL] [Abstract] [Full Text] [Related]
12. The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in liver Transplantation for Hepatocellular Carcinoma.
Lu D; Yang F; Zhuo J; Yang M; Lin Z; Jin P; Cai X; Cen B; Wang J; Wei X; Zheng S; Xu X
Clin Transl Gastroenterol; 2020 May; 11(5):e00168. PubMed ID: 32358239
[TBL] [Abstract] [Full Text] [Related]
13. Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.
Zhang H; Zhou Y; Li Y; Qin W; Zi Y; Liu Y; Qiu X; Xu H; Liao W; Huang Z
BMC Cancer; 2020 Feb; 20(1):132. PubMed ID: 32070301
[TBL] [Abstract] [Full Text] [Related]
14. Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017.
Lattuca-Truc M; Timsit JF; Levra MG; Ruckly S; Villa J; Dumas I; Pinsolle J; Ferrer L; Guillem P; Moro-Sibilot D; Toffart AC;
Lung Cancer; 2019 May; 131():122-127. PubMed ID: 31027688
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.
Li S; Xu H; Wu C; Wang W; Jin W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Liu L
Cancer Med; 2019 Feb; 8(2):572-584. PubMed ID: 30632317
[TBL] [Abstract] [Full Text] [Related]
16. Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.
Qu Z; Ling Q; Gwiasda J; Xu X; Schrem H; Beneke J; Kaltenborn A; Krauth C; Mix H; Klempnauer J; Emmanouilidis N
Langenbecks Arch Surg; 2018 Aug; 403(5):643-654. PubMed ID: 30120543
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract] [Full Text] [Related]
18. Down-Regulation of LncRNA DGCR5 Correlates with Poor prognosis in Hepatocellular Carcinoma.
Huang R; Wang X; Zhang W; Zhangyuan G; Jin K; Yu W; Xie Y; Xu X; Wang H; Sun B
Cell Physiol Biochem; 2016; 40(3-4):707-715. PubMed ID: 27898409
[TBL] [Abstract] [Full Text] [Related]
19. Loss of SMAD4 Promotes Lung Metastasis of Colorectal cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
[TBL] [Abstract] [Full Text] [Related]
20. MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
OuYang HY; Xu J; Luo J; Zou RH; Chen K; Le Y; Zhang YF; Wei W; Guo RP; Shi M
Hepatology; 2016 Apr; 63(4):1227-39. PubMed ID: 26660154
[TBL] [Abstract] [Full Text] [Related]
[Next]
